ALNY
ALNYLAM PHARMACE
Health Care·Biotechnology·UNITED STATES
$229.30
MCap $30.7B
as of 2026-08-20
Total
D3w
Fund
C3w
Quant
E9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
+0.04
Sentiment 39.9%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$229.30
Adaptive Mean
$228.53
+0.77 vs mean
Adaptive σ
9.32
MIDOS BB
$209.90 – $247.16
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+1.01
ROE
96.6%
Z +1.68
Rev Gr
66.9%
Z +0.51
EPS Gr
—
Z +0.07
OPM Gr
20.0%
Z +4.15
FCF Yld
0.9%
Z +0.17
EPS Surp
-0.1%
Z +0.35
EPS 3mo Δ
-20.2%
Z +0.12
Fwd P/E
18.66
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
-6.49
Q6M
-7.43
Q12M
-8.55
MA 30/100
0.868
Bearish (MA30 < MA100)
α (Jensen)
-0.7608
β (12M)
0.32
σ (12M)
0.459
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
3%
Divergence
+94.5
Tier
RELOAD — WATCH
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
-39.2
RS Pctl
9%
RS Decile
D1
Persistence
3w
at grade D
Options / OI Analysis
No options or Williams data available for this ticker.